Projects per year
Personal profile
Biography
Graduated from the University of Cambridge in 2012 including an intercalated degree in Pharmacology (1st). He then undertook a Respiratroy Academic Foundation Job affiliated with the University of East Anglia and NHS Norfolk and Norwich. During these 2 years he obtained his MRCP(UK).
Following his Foundation Years, Mark worked for a year in Canberra, Australia. He obtained registration with the Australian Medical Council and retains registration. He returned to Scotland to undertake Core Medical Training, including a rotation at the Beatson West of Scotland Cancer Centre.
He began Specialty training in Medical Oncology in 2017 before taking up a SCREDS Clinical Lectureship with Prof Petty at the University of Dundee. He obtained CSO funding to undertake a 3 year PhD focussed on frailty in advanced gastroesophageal cancer and began this in August 2020.
Research
CSO Clinical Academic Fellow
Chair of NOTCH (National Oncology Trainee Collaborative for Healthcare Research)
Research interests
Frailty in advanced cancer
Biomarkers for chemosensitivity
Supportive care
Quality of life
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PGCert THE
Award Date: 1 May 2018
Doctor of Medicine, University of Cambridge
Award Date: 27 Jun 2012
Bachelor of Arts, University of Cambridge
1 Oct 2006 → 30 Jun 2009
Award Date: 30 Jun 2009
External positions
Medical Oncology Registrar, NHS Tayside
10 Sep 2018 → …
Keywords
- RC0254 Neoplasms. Tumors. Oncology (including Cancer)
- Frailty
- Geriatric Oncology
- Toxicity
- Gastric cancer
- Oesophageal cancer
Fingerprint
- 1 Similar Profiles
Network
-
Establishing DNA Damage Response-Deficient (DDRD) Status in Patients with Advanced Oesophageal Adenocarcinoma who have had an Exceptional Response to First Line Chemotherapy
Baxter, M., Petty, R. & Walsh, S.
1/03/19 → 31/08/19
Project: Research
Research output
-
Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer
Stares, M., Ding, T. E., Stratton, C., Thomson, F., Baxter, M., Cagney, H., Cumming, K., Swan, A., Ross, F., Barrie, C., Maclennan, K., Campbell, S., Evans, T., Tufail, A., Harrow, S., Lord, H., Laird, B., MacKean, M. & Phillips, I., Apr 2022, In: ESMO open. 7, 2, 8 p., 100445.Research output: Contribution to journal › Article › peer-review
Open AccessFile12 Downloads (Pure) -
Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the young international society of geriatric oncology
Baxter, M. A., Marinho, J., Soto-Perez-de-Celis, E., Rodriquenz, M. G., Arora, S. P., Lok, W. C. W., Shih, Y-Y., Liposits, G., O'Hanlon, S. & Petty, R. D., Jan 2022, In: Journal of Geriatric Oncology. 13, 1, p. 7-19 13 p.Research output: Contribution to journal › Review article › peer-review
-
'Oncological trials-designed for result or clinical relevance?'
Baxter, M. A. & O'Hanlon, S., May 2022, In: Age and Ageing. 51, 5, 2 p., afac103.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Acute renal transplant rejection following nivolumab therapy for metastatic melanoma
Tan, B., Baxter, M. & Casasola, R., 8 Feb 2021, In: BMJ Case Reports. 14, 2, 6 p., e238037.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)77 Downloads (Pure) -
Best supportive care and prognosis: advanced gastroesophageal adenocarcinoma
Cavanagh, K. E., Baxter, M. A. & Petty, R. D., 23 Jul 2021, (E-pub ahead of print) In: BMJ Supportive & Palliative Care. 5 p., e002637.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)20 Downloads (Pure)